# Major Advisory Alert: Important Update on WATCHMAN FXD Curve™ Access System, TruSteer™, and TruSeal™ Due to Air Embolism Risk
On **July 29, 2025**, **Boston Scientific** issued an advisory involving their WATCHMAN FXD Curve™ Access System, TruSteer™, and TruSeal™ Access Systems. This crucial update addresses information related to the **potential risk of air embolism during WATCHMAN™ procedures**. While this is not a product recall, the advisory is a proactive effort to ensure patient safety and provide healthcare professionals with critical guidance to mitigate risks.
Stay informed and learn what to do if the advisory impacts you or your loved ones.
---
## Why This Advisory Is Important
Boston Scientific’s WATCHMAN™ systems play a pivotal role in **minimally invasive procedures to reduce stroke risk** in patients with atrial fibrillation. However, the **potential for air embolism** during these procedures has prompted the company to issue this advisory.
### What Is an Air Embolism?
An air embolism occurs when air bubbles enter a vein or artery, potentially obstructing blood flow. If not promptly addressed, this issue can lead to life-threatening complications, such as stroke or cardiovascular distress. In healthcare settings, awareness of this risk is critical to protecting patient health.
By issuing this advisory, **Boston Scientific** aims to **raise awareness among healthcare providers about risk minimization techniques during WATCHMAN™ procedures** to enhance patient safety.
---
## Details of the Advisory
Here’s a breakdown of the essential details surrounding the Boston Scientific advisory:
- **Product Names Involved**:
- WATCHMAN FXD Curve™ Access System
- WATCHMAN TruSteer™ Access System
- WATCHMAN™ TruSeal™ Access System
- **Advisory Reason**:
The company has identified the **potential for air embolism** during WATCHMAN™ procedures. No products have been recalled, but careful procedural guidance has been issued to minimize risks.
- **Advisory Start Date**:
**July 29, 2025**
- **Impact**:
The advisory is directed at healthcare providers performing WATCHMAN™ procedures. Boston Scientific emphasizes that **products will remain available for use**, but extra caution and procedural improvements are necessary.
For more official details, visit the Canadian government's website: [Official Recall Source](https://recalls-rappels.canada.ca/en/alert-recall/watchmantm-access-systems).
---
## What You Should Do
If you or a loved one has received a WATCHMAN™ procedure, or if you're a healthcare professional using these products, take these steps:
- **Patients**:
- Contact your healthcare provider if you have concerns regarding recent or upcoming WATCHMAN™ procedures.
- Monitor your health for any symptoms of complications, such as chest pain, shortness of breath, or dizziness, and seek immediate medical attention if these occur.
- **Healthcare Providers**:
- Review Boston Scientific's procedural guidance to ensure adherence to best practices that mitigate the risk of air embolism.
- Stay informed about any updates or additional safety measures provided by the manufacturer.
Being proactive and informed is vital in ensuring safety for those impacted by this advisory.
---
## Stay Safe – Get Instant Recall Alerts
In today’s fast-paced world, staying informed about product safety is essential. With regular updates and alerts on advisories like this one, you can protect yourself and your loved ones from unexpected risks.
**Download our mobile app today for real-time updates on recalls and safety alerts.** Don’t miss critical health and safety information—stay ahead with our app at your fingertips!
---
Boston Scientific’s commitment to protecting patient safety underscores the importance of this advisory. **If you’re directly or indirectly impacted, take action now to ensure safety, and stay informed about any further developments.**
For the official details, please visit the [Canadian recall website here](https://recalls-rappels.canada.ca/en/alert-recall/watchmantm-access-systems).